Flower remains the commercial backbone of most dispensaries in Colorado, Washington and Oregon. Consider: In 2016, flower captured 58 percent of the cannabis marketplace, with $1.35 billion in sales out of an overall $2.33 billion market. Flower’s market share is dropping (it was 64 percent of the market in 2015) but sales are still way up from 2015, by 41.3 percent, according to BDS Analytics, a leading cannabis data analytics firm.
The rise of flower would have been even more pronounced if not for regulatory hiccups in Oregon (loud ones) towards the end of 2016, and a subtle migration of sales away from medical dispensaries in Colorado during the year.
During the fourth quarter of 2016, according to BDS Analytics, we see flower (in terms of dollar sales) up 22.8 percent (to $364.86 million) compared to the same quarter in 2015 in all states collectively. In Colorado’s adult use market, it’s up by 33.4 percent (to $129.31 million), but in the medical market sales fell by 3.9 percent (to $57.04 million). Meanwhile, in Oregon’s medical market sales positively plummeted during the fourth quarter, down 83.2 percent (at $11.46 million) compared to 2015.
Sales of $120.97 million in Q4 2016 in Washington State, on the other hand, represent a rise of 66.5 percent compared to Q4 2015. And in terms of units sold, sales more than doubled — up 103.1 percent to 19.4 million units.
Some things don’t change much, however. Between all states during Q4 2015 the breakdown of cannabis styles was 64 percent hybrid, with indica and sativa tied at 18 percent. During Q4 2016 it was 63 percent hybrid, 19 percent sativa and 18 percent indica.